News

EMUC20 EUPROMS

EMUC20: Highlights in GU cancers

Active surveillance should be considered the first treatment for prostate cancer in order to ensure the best quality of life. This was one of the key messages of Mr. André Deschamps’ (BE) presentation during the “Highlights in GU cancers”...

EMUC20 is now a Virtual Congress!

In a change for uro-oncology experts across Europe, the 12th European Multidisciplinary Congress on Urological Cancers (EMUC20) is now a two-day virtual congress. While the organisers had hoped that the EMUC congress could be held physically like every year, the...

EMUC19: HoT courses highlight MRI reading and fusion biopsy

Two Hands-on Training (HoT) courses organised by the European School of Urology (ESU) and the EAU Section of Urological Imaging (ESUI) simultaneously commenced on day 2 of the 11th European Multidisciplinary Congress on Urological Cancers (EMUC19). The ESU/ESUI Hands-on Training...

EMUC19: Urine biomarkers may detect disease state in NMIBC

The Scientific Programme of the EMUC congress is well-known for its broad coverage of relevant and current updates on genitourinary (GU) malignancies. The upcoming 11th European Multidisciplinary Congress on Urological Cancers (EMUC19) will be no different. One of its...

EMUC19: What to do when faced with a nightmare PCa case

Imagine a treatment strategy not working on your patient. The situation escalates and the patient suffers from complications. What do you do? The “Nightmare Session: It could happen to you…” at the upcoming 11th European Multidisciplinary Congress on Urological Cancers (EMUC19)...
EMUC-Birtle-POUT

EMUC18: Updates on notable trials

Developments of notable trials were announced today during Plenary Session 06 New trials update: What we need to know which was chaired by Dr. Laurence Colette (BE), Dr. Ganesh Palapattu (US), Dr. Stephen Boorjian (US) and Dr. Alberto Bossi (FR). In his...
ESUI-De-Visschere

ESUI18: Prospects and impact of emerging imaging technologies

The rise of artificial intelligence, imaging-related toxicities, and other cutting-edge topics were featured during the session “Back to the future part I: What to expect in the next decade?”, which was moderated by  Prof. Dr. Jurgen Futterer  (NL), Prof....

EMUC18: Crucial MDT work in urological cancers

Multidisciplinary teams (MDTs) help achieve optimal management of urological malignancies, but more than putting MDTs in place, experts are in agreement that a lot more needs to be done to support and increase the contacts and links among various...

BCa18: Road maps in personalising bladder cancer treatment

Bladder cancer, one of the most aggressive recurrent onco-urological malignancies, poses a special challenge to cancer experts due to the lack of response from many patients particularly  those who are diagnosed at a late stage. The EAU Update on...